Cargando…

Impact of type 2 diabetes mellitus on mid-term mortality for hypertrophic cardiomyopathy patients who underwent septal myectomy

BACKGROUND: Type 2 diabetes mellitus is common in cardiovascular disease. It is associated with adverse clinical outcomes for patients who had undergone coronary artery bypass and valve operations. The aim of this study was to evaluate the impact of type 2 diabetes mellitus on the midterm outcomes o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shengwei, Cui, Hao, Ji, Keshan, Song, Changpeng, Ren, Changwei, Guo, Hongchang, Zhu, Changsheng, Wang, Shuiyun, Lai, Yongqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222568/
https://www.ncbi.nlm.nih.gov/pubmed/32404127
http://dx.doi.org/10.1186/s12933-020-01036-1
_version_ 1783533604306944000
author Wang, Shengwei
Cui, Hao
Ji, Keshan
Song, Changpeng
Ren, Changwei
Guo, Hongchang
Zhu, Changsheng
Wang, Shuiyun
Lai, Yongqiang
author_facet Wang, Shengwei
Cui, Hao
Ji, Keshan
Song, Changpeng
Ren, Changwei
Guo, Hongchang
Zhu, Changsheng
Wang, Shuiyun
Lai, Yongqiang
author_sort Wang, Shengwei
collection PubMed
description BACKGROUND: Type 2 diabetes mellitus is common in cardiovascular disease. It is associated with adverse clinical outcomes for patients who had undergone coronary artery bypass and valve operations. The aim of this study was to evaluate the impact of type 2 diabetes mellitus on the midterm outcomes of patients with hypertrophic cardiomyopathy who underwent septal myectomy. METHODS: We retrospectively analyzed the data of 67 hypertrophic cardiomyopathy patients with type 2 diabetes mellitus who underwent septal myectomy from two medical centers in China from 2011 to 2018. A propensity score–matched cohort of 134 patients without type 2 diabetes mellitus was also analyzed. RESULTS: During a median follow-up of 28.0 (interquartile range: 13.0–3.0) months, 9 patients died. The cause of death of all of these patients was cardiovascular, particularly sudden cardiac death in 3 patients. Patients with type 2 diabetes mellitus had a higher rate of sudden cardiac death (4.5% vs. 0.0%, p = 0.04). The Kaplan–Meier survival analysis revealed that the rates of predicted 3-year survival free from cardiovascular death (98.1% vs. 95.1%, p = 0.14) were similar between the two groups. However, the rates of predicted 3-year survival free from sudden cardiac death (100% vs. 96.7%, p = 0.01) were significantly higher in hypertrophic cardiomyopathy patients without type 2 diabetes mellitus than in those with type 2 diabetes mellitus. Furthermore, after adjustment for age and sex, only N-terminal pro-brain natriuretic peptide (hazards ratio: 1.002, 95% confidence interval: 1.000–1.005, p = 0.02) and glomerular filtration rate ≤ 80 ml/min (hazards ratio: 3.23, 95% confidence interval: 1.34–7.24, p = 0.047) were independent risk factors for hypertrophic cardiomyopathy patients with type 2 diabetes mellitus. CONCLUSIONS: Hypertrophic cardiomyopathy patients with and without type 2 diabetes mellitus have similar 3-year cardiovascular mortality after septal myectomy. However, type 2 diabetes mellitus is associated with higher sudden cardiac death rate in these patients. In addition, N-terminal pro-brain natriuretic peptide and glomerular filtration rate ≤ 80 ml/min were independent risk factors among hypertrophic cardiomyopathy patients with type 2 diabetes mellitus.
format Online
Article
Text
id pubmed-7222568
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72225682020-05-27 Impact of type 2 diabetes mellitus on mid-term mortality for hypertrophic cardiomyopathy patients who underwent septal myectomy Wang, Shengwei Cui, Hao Ji, Keshan Song, Changpeng Ren, Changwei Guo, Hongchang Zhu, Changsheng Wang, Shuiyun Lai, Yongqiang Cardiovasc Diabetol Original Investigation BACKGROUND: Type 2 diabetes mellitus is common in cardiovascular disease. It is associated with adverse clinical outcomes for patients who had undergone coronary artery bypass and valve operations. The aim of this study was to evaluate the impact of type 2 diabetes mellitus on the midterm outcomes of patients with hypertrophic cardiomyopathy who underwent septal myectomy. METHODS: We retrospectively analyzed the data of 67 hypertrophic cardiomyopathy patients with type 2 diabetes mellitus who underwent septal myectomy from two medical centers in China from 2011 to 2018. A propensity score–matched cohort of 134 patients without type 2 diabetes mellitus was also analyzed. RESULTS: During a median follow-up of 28.0 (interquartile range: 13.0–3.0) months, 9 patients died. The cause of death of all of these patients was cardiovascular, particularly sudden cardiac death in 3 patients. Patients with type 2 diabetes mellitus had a higher rate of sudden cardiac death (4.5% vs. 0.0%, p = 0.04). The Kaplan–Meier survival analysis revealed that the rates of predicted 3-year survival free from cardiovascular death (98.1% vs. 95.1%, p = 0.14) were similar between the two groups. However, the rates of predicted 3-year survival free from sudden cardiac death (100% vs. 96.7%, p = 0.01) were significantly higher in hypertrophic cardiomyopathy patients without type 2 diabetes mellitus than in those with type 2 diabetes mellitus. Furthermore, after adjustment for age and sex, only N-terminal pro-brain natriuretic peptide (hazards ratio: 1.002, 95% confidence interval: 1.000–1.005, p = 0.02) and glomerular filtration rate ≤ 80 ml/min (hazards ratio: 3.23, 95% confidence interval: 1.34–7.24, p = 0.047) were independent risk factors for hypertrophic cardiomyopathy patients with type 2 diabetes mellitus. CONCLUSIONS: Hypertrophic cardiomyopathy patients with and without type 2 diabetes mellitus have similar 3-year cardiovascular mortality after septal myectomy. However, type 2 diabetes mellitus is associated with higher sudden cardiac death rate in these patients. In addition, N-terminal pro-brain natriuretic peptide and glomerular filtration rate ≤ 80 ml/min were independent risk factors among hypertrophic cardiomyopathy patients with type 2 diabetes mellitus. BioMed Central 2020-05-13 /pmc/articles/PMC7222568/ /pubmed/32404127 http://dx.doi.org/10.1186/s12933-020-01036-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Original Investigation
Wang, Shengwei
Cui, Hao
Ji, Keshan
Song, Changpeng
Ren, Changwei
Guo, Hongchang
Zhu, Changsheng
Wang, Shuiyun
Lai, Yongqiang
Impact of type 2 diabetes mellitus on mid-term mortality for hypertrophic cardiomyopathy patients who underwent septal myectomy
title Impact of type 2 diabetes mellitus on mid-term mortality for hypertrophic cardiomyopathy patients who underwent septal myectomy
title_full Impact of type 2 diabetes mellitus on mid-term mortality for hypertrophic cardiomyopathy patients who underwent septal myectomy
title_fullStr Impact of type 2 diabetes mellitus on mid-term mortality for hypertrophic cardiomyopathy patients who underwent septal myectomy
title_full_unstemmed Impact of type 2 diabetes mellitus on mid-term mortality for hypertrophic cardiomyopathy patients who underwent septal myectomy
title_short Impact of type 2 diabetes mellitus on mid-term mortality for hypertrophic cardiomyopathy patients who underwent septal myectomy
title_sort impact of type 2 diabetes mellitus on mid-term mortality for hypertrophic cardiomyopathy patients who underwent septal myectomy
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222568/
https://www.ncbi.nlm.nih.gov/pubmed/32404127
http://dx.doi.org/10.1186/s12933-020-01036-1
work_keys_str_mv AT wangshengwei impactoftype2diabetesmellitusonmidtermmortalityforhypertrophiccardiomyopathypatientswhounderwentseptalmyectomy
AT cuihao impactoftype2diabetesmellitusonmidtermmortalityforhypertrophiccardiomyopathypatientswhounderwentseptalmyectomy
AT jikeshan impactoftype2diabetesmellitusonmidtermmortalityforhypertrophiccardiomyopathypatientswhounderwentseptalmyectomy
AT songchangpeng impactoftype2diabetesmellitusonmidtermmortalityforhypertrophiccardiomyopathypatientswhounderwentseptalmyectomy
AT renchangwei impactoftype2diabetesmellitusonmidtermmortalityforhypertrophiccardiomyopathypatientswhounderwentseptalmyectomy
AT guohongchang impactoftype2diabetesmellitusonmidtermmortalityforhypertrophiccardiomyopathypatientswhounderwentseptalmyectomy
AT zhuchangsheng impactoftype2diabetesmellitusonmidtermmortalityforhypertrophiccardiomyopathypatientswhounderwentseptalmyectomy
AT wangshuiyun impactoftype2diabetesmellitusonmidtermmortalityforhypertrophiccardiomyopathypatientswhounderwentseptalmyectomy
AT laiyongqiang impactoftype2diabetesmellitusonmidtermmortalityforhypertrophiccardiomyopathypatientswhounderwentseptalmyectomy